Skip to main content
Toggle Menu of ADA WebSites
ADA Websites
Partnerships and Commissions
Toggle Search Area
Toggle Menu
e-mail Print Share

Call for Comments on New ADA Clinical Practice Guideline on the Use of Antibiotics for the Emergency Management of Dental Pain and Swelling

Thank you to everyone who submitted feedback concerning the ADA's upcoming clinical practice guideline on the use of antibiotics for the emergency management of symptomatic irreversible pulpitis, symptomatic apical periodontitis, and localized acute apical abscess. The deadline to submit comments on the guideline's recommendations and good practice statements has passed. The ADA’s Center for Evidence-Based Dentistry (EBD), working with an expert panel convened by the ADA's Council on Scientific Affairs, is currently reviewing all submitted comments and using them to inform the guideline's development.

How were these recommendations and good practice statements developed?

The ADA’s upcoming guideline was informed by a systematic review of the best available scientific evidence conducted by the ADA's Center for EBD. This review, developed in consultation with an expert panel chaired by Dr. Peter Lockhart of the Carolinas Medical Center, resulted in the guideline's recommendations and good practice statements.

Where will these recommendations and good practice statements ultimately be published? 

These recommendations and good practice statements will appear in the upcoming guideline, which will be submitted for publication in the Journal of the American Dental Association. Those attending ADA 2019 in San Francisco, September 4 to 9, can also hear two of the guideline's authors, Drs. Elliot Abt and Peter Lockhart, present the guideline's recommendations and good practice statements during the course "Combating Antibiotic Resistance Starts in Your Dental Chair! ADA Clinical Practice Guideline Series." Registration details for this course are to come.

Where can I go for additional information?

To be put on an email list notifying you when this guideline is published, or if you have any questions about the guideline development process, please email the ADA Center for EBD at ebd@ada.org.

View all ADA guidelines